MedTrace Logo

Automatic Sound Management 3.0 in a Single-unit Audio Processor

NCT04918654 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-11-21

No results posted yet for this study

Summary

Cochlear implants are routine treatment for people with severe hearing loss. This study tests the RONDO 3, MED-EL's newest single-unit audio processor which comes with new features (Beamformer, Wind-Noise reduction, Ambient noise reduction, Transient noise reduction, Adaptive intelligence).

Conditions

  • Cochlear Implants

Sponsors & Collaborators

  • Hannover Medical School

    collaborator OTHER

  • MED-EL Elektromedizinische Geräte GesmbH

    lead INDUSTRY

Principal Investigators

  • Andreas Büchner, Prof. Dr. · Hals-Nasen-Ohrenklinik der Medizinischen Hochschule Hannover

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-25
Primary Completion
2023-12-11
Completion
2023-12-11

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04918654 on ClinicalTrials.gov